The treatment has been used in a similar case.
‘The dad of a kid with a similar disability as young Charlie Gard made an emotional and moving plea on behalf of the Gard family.
Peter Smith’s son, Maxwell, has benefitted from the nucleoside therapy which Charlie’s parents desperately want for their son.
As Smith spoke with ITV’s This Morning, he was moved to tears, and spoke about his son’s improvement after the experimental treatment.’
http://ussanews.com/News1/2017/07/10/father-of-disabled-child-makes-emotional-plea-for-charlie-gard/
‘The dad of a kid with a similar disability as young Charlie Gard made an emotional and moving plea on behalf of the Gard family.
I have read about this, and seen several claims that as many as 18 kids have been treated.
These kids, however, have a different disease than little Charlie. They have thymidine kinase 2 (tk2) deficiency. Charlie has ribonucleotide reductase small subunit 2 b (RRM2B) mutation. He is the 16th child diagnosed with this disease, and no child afflicted has ever lived beyond a few months. Nor has any child with RRM2B mutation ever been treated.
I did some analysis the other night: Post 47.